20
Fertin Pharma As, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NICOTINE POLACRILEX USP, with a corresponding US DMF Number 20123.
Remarkably, this DMF maintains an Active status since its submission on January 08, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 23, 2012, and payment made on November 16, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II